Literature DB >> 20819043

Brain abnormalities detected on magnetic resonance imaging of amphetamine users presenting to an emergency department: a pilot study.

Daniel M Fatovich1, David L McCoubrie, Swithin J Song, David M Rosen, Nick D Lawn, Frank F Daly.   

Abstract

OBJECTIVES: To determine the prevalence of occult brain abnormalities in magnetic resonance imaging of active amphetamine users. DESIGN, SETTING AND PARTICIPANTS: Prospective convenience study in a tertiary hospital emergency department (ED). Patients presenting to the ED for an amphetamine-related reason were eligible for inclusion. We collected demographic data, drug use data, and performed a mini-mental state examination (MMSE). MAIN OUTCOME MEASURES: The proportion of patients with an abnormality on their MRI scan.
RESULTS: Of 38 patients enrolled, 30 had MRI scans. Nineteen were male and their mean age was 26.7 +/- 5.4 years (range 19-41 years). The mean age of first amphetamine use was 18 years (range 13-26 years). Sixteen patients used crystal methamphetamine (mean amount 2.5 g/week), nine used amphetamine ("speed") (mean amount 2.9 g/week), and 23 used ecstasy (mean amount 2.3 tablets/week). Marijuana was smoked by 26 (mean amount 5.9 g/week), and 28 drank alcohol (mean amount 207 g/week). The median MMSE score was 27/30 (interquartile range, 26-29). Abnormalities on brain MRI scans were identified in six patients, most commonly an unidentified bright object (n = 4).
CONCLUSION: In this pilot study of brain MRI of young people attending the ED with an amphetamine-related presentation, one in five had an occult brain lesion. While the significance of this is uncertain, it is congruent with evidence that amphetamines cause brain injury.

Entities:  

Mesh:

Year:  2010        PMID: 20819043     DOI: 10.5694/j.1326-5377.2010.tb03904.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome.

Authors:  An N Dang Do; Eva H Baker; Katherine E Warren; Simona E Bianconi; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2017-12-11       Impact factor: 2.802

2.  Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia.

Authors:  Huabing Li; Qiong Lu; Enhua Xiao; Qiuyun Li; Zhong He; Xilong Mei
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.